The Securities Law Firm of KlaymanToskes, www.klaymantoskes.com, with offices in California, Florida and New York, announced today that it is continuing to pursue claims on behalf of investors from across the country that have lost money in Medical Capital Notes. KlaymanToskes has filed securities arbitration claims against various brokerage firms on behalf of investors, to recover losses sustained in Medical Capital Notes, with the Financial Industry Regulatory Authority (“FINRA”).
On July 16, 2009, the Securities and Exchange Commission (“SEC”) filed fraud charges against Medical Capital Holdings in connection with the sale of $77 million of private securities. On the same day, FINRA issued a sweep notice to obtain information from several brokerage firms regarding the sale of Medical Capital securities. Since that time, KlaymanToskes has been retained by numerous Medical Capital investors who have sustained significant damages.
While a class action lawsuit has been filed regarding Medical Capital Notes, KlaymanToskes reminds investors of the benefits of filing an individual securities arbitration claim, as opposed to participating in a class action lawsuit. By participating in a class action lawsuit, an investor may only recover a nominal amount. However, if one has experienced significant losses in Medical Capital Notes, it may be more beneficial for them to file an individual securities arbitration claim. In 2003, KlaymanToskes conducted a detailed study of securities arbitration versus class action. The study concluded that investors who file a securities arbitration claim traditionally obtain an overall higher rate of recovery as opposed to participating in a class action lawsuit. To view the full results of the comparison, please the following link: https://klaymantoskes.com/documents/classvr.pdf
Investors who purchased Medical Capital securities from a full-service brokerage firm and sustained significant losses can contact KlaymanToskes to explore their legal rights and options. The attorneys at KlaymanToskes are dedicated to pursuing claims on behalf of investors who have suffered investment losses. KlaymanToskes, an experienced, qualified and nationally recognized securities litigation law firm, practices exclusively in the field of securities arbitration and litigation. It continues its representation of investors throughout the world in securities arbitration and litigation matters against major Wall Street brokerage firms. KlaymanToskes is presently representing investors from across the country who invested in Medical Capital Notes.